Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | 2C20H18NO4.O4S |
| Molecular Weight | 768.785 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[O-]S([O-])(=O)=O.COC1=C(OC)C2=C(C=C1)C=C3C4=CC5=C(OCO5)C=C4CC[N+]3=C2.COC6=C(OC)C7=C(C=C6)C=C8C9=CC%10=C(OCO%10)C=C9CC[N+]8=C7
InChI
InChIKey=OJVABJMSSDUECT-UHFFFAOYSA-L
InChI=1S/2C20H18NO4.H2O4S/c2*1-22-17-4-3-12-7-16-14-9-19-18(24-11-25-19)8-13(14)5-6-21(16)10-15(12)20(17)23-2;1-5(2,3)4/h2*3-4,7-10H,5-6,11H2,1-2H3;(H2,1,2,3,4)/q2*+1;/p-2
| Molecular Formula | O4S |
| Molecular Weight | 96.063 |
| Charge | -2 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C20H18NO4 |
| Molecular Weight | 336.3612 |
| Charge | 1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionCurator's Comment: description was created based on several sources, including:
https://examine.com/supplements/berberine/ | https://www.ncbi.nlm.nih.gov/pubmed/19686830 | https://www.ncbi.nlm.nih.gov/pubmed/25610485
Curator's Comment: description was created based on several sources, including:
https://examine.com/supplements/berberine/ | https://www.ncbi.nlm.nih.gov/pubmed/19686830 | https://www.ncbi.nlm.nih.gov/pubmed/25610485
Berberine, an alkaloid isolated from Rhizoma Coptidis, is known to have a wide array of therapeutic effects including antimicrobial, antineoplastic, and hepatoprotective effects. It is found in several plants including European barberry, goldenseal, goldthread, Oregon grape, phellodendron, and tree tumeric. Berberine seems to slightly reduce blood sugar levels in people with diabetes. Berberine might lower blood pressure. Berberine is possibly safe for most adults for short-term use when taken by mouth or applied to the skin.
CNS Activity
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Evaluation of natural products as inhibitors of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase. | 1991 Jan-Feb |
|
| [Determination of berberine in human serum by reversed-phase high performance liquid chromatography]. | 1997 Sep |
|
| Screening of compounds for antimicrosporidial activity in vitro. | 1998 |
|
| The effect of Kampo formulae on bone resorption in vitro and in vivo. I. Active constituents of Tsu-kan-gan. | 1998 Dec |
|
| Antitubercular natural products: berberine from the roots of commercial Hydrastis canadensis powder. Isolation of inactive 8-oxotetrahydrothalifendine, canadine, beta-hydrastine, and two new quinic acid esters, hycandinic acid esters-1 and -2. | 1998 Oct |
|
| Differential inhibitory effects of protoberberines on sterol and chitin biosyntheses in Candida albicans. | 1999 May |
|
| Identification of three sulfate-conjugated metabolites of berberine chloride in healthy volunteers' urine after oral administration. | 2002 Jan |
|
| Effect of artemisinin/artesunate as inhibitors of hepatitis B virus production in an "in vitro" replicative system. | 2005 Nov |
|
| Berberine enhances inhibition of glioma tumor cell migration and invasiveness mediated by arsenic trioxide. | 2008 Feb 25 |
|
| Anti-diabetic effects of cinnamaldehyde and berberine and their impacts on retinol-binding protein 4 expression in rats with type 2 diabetes mellitus. | 2008 Nov 5 |
|
| Berberine suppresses intestinal disaccharidases with beneficial metabolic effects in diabetic states, evidences from in vivo and in vitro study. | 2010 Apr |
|
| Characterization of protoberberine analogs employed as novel human P2X7 receptor antagonists. | 2011 Apr 15 |
|
| Berberine down-regulates the Th1/Th2 cytokine gene expression ratio in mouse primary splenocytes in the absence or presence of lipopolysaccharide in a preventive manner. | 2011 Dec |
|
| Berberine protects against lipopolysaccharide-induced intestinal injury in mice via alpha 2 adrenoceptor-independent mechanisms. | 2011 Nov |
|
| Structure-activity studies of some berberine analogs as inhibitors of Toxoplasma gondii. | 2012 Apr 15 |
|
| Mechanism study of goldenseal-associated DNA damage. | 2013 Jul 31 |
|
| Berberine, a natural antidiabetes drug, attenuates glucose neurotoxicity and promotes Nrf2-related neurite outgrowth. | 2013 Nov 1 |
|
| The potential effect of berberine in mercury-induced hepatorenal toxicity in albino rats. | 2014 Jul |
|
| Multiple mechanisms of cell death induced by chelidonine in MCF-7 breast cancer cell line. | 2014 Nov 5 |
|
| Berberine promotes bone marrow-derived mesenchymal stem cells osteogenic differentiation via canonical Wnt/β-catenin signaling pathway. | 2016 Jan 5 |
Sample Use Guides
500 mg of berberine 2-3 times daily for up to 3 months
Route of Administration:
Oral
Berberine acted cytotoxically on both tumour cell lines. The melanoma B16 cells were much more sensitive to berberine treatment than the U937 cells. The value of IC(100) was below 100 ug/ml for the U937 cells and below 1 ug/ml for the B16 cells. As for both cell lines under the long-term influence the values of IC(50) were found to be less than 4 ug/ml.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:17:56 GMT 2023
by
admin
on
Fri Dec 15 16:17:56 GMT 2023
|
| Record UNII |
FST3E667FF
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
100000077186
Created by
admin on Fri Dec 15 16:17:56 GMT 2023 , Edited by admin on Fri Dec 15 16:17:56 GMT 2023
|
PRIMARY | |||
|
316-41-6
Created by
admin on Fri Dec 15 16:17:56 GMT 2023 , Edited by admin on Fri Dec 15 16:17:56 GMT 2023
|
PRIMARY | |||
|
SUB13046MIG
Created by
admin on Fri Dec 15 16:17:56 GMT 2023 , Edited by admin on Fri Dec 15 16:17:56 GMT 2023
|
PRIMARY | |||
|
CHEMBL295124
Created by
admin on Fri Dec 15 16:17:56 GMT 2023 , Edited by admin on Fri Dec 15 16:17:56 GMT 2023
|
PRIMARY | |||
|
206-258-2
Created by
admin on Fri Dec 15 16:17:56 GMT 2023 , Edited by admin on Fri Dec 15 16:17:56 GMT 2023
|
PRIMARY | |||
|
DBSALT002312
Created by
admin on Fri Dec 15 16:17:56 GMT 2023 , Edited by admin on Fri Dec 15 16:17:56 GMT 2023
|
PRIMARY | |||
|
2170
Created by
admin on Fri Dec 15 16:17:56 GMT 2023 , Edited by admin on Fri Dec 15 16:17:56 GMT 2023
|
PRIMARY | |||
|
9424
Created by
admin on Fri Dec 15 16:17:56 GMT 2023 , Edited by admin on Fri Dec 15 16:17:56 GMT 2023
|
PRIMARY | |||
|
FST3E667FF
Created by
admin on Fri Dec 15 16:17:56 GMT 2023 , Edited by admin on Fri Dec 15 16:17:56 GMT 2023
|
PRIMARY | |||
|
5355
Created by
admin on Fri Dec 15 16:17:56 GMT 2023 , Edited by admin on Fri Dec 15 16:17:56 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE | |||
|
SOLVATE->ANHYDROUS |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |